Evidence map›Paper›PMID 30500874›Full record

ArticleJournal of Crohn's & colitis2019

A Genome-wide Association Study Identifying RAP1A as a Novel Susceptibility Gene for Crohn's Disease in Japanese Individuals.

Yoichi Kakuta, Yosuke Kawai, Takeo Naito, Atsushi Hirano, Junji Umeno, Yuta Fuyuno, Zhenqiu Liu, Dalin Li, Takeru Nakano, Yasuhiro Izumiyama and 26 more

Open access · greenAbstract read
In one paragraph

Article in Journal of Crohn's & colitis, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. JGH open : an open access journal of gastroenterology and hepatology · 2020
    Article
  14. Observational
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors at 6 institutions in 1 country.

Yoichi KakutaDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yosuke KawaiTohoku Medical Megabank Organisation, Tohoku University, Sendai, Japan.
Takeo NaitoDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Atsushi HiranoDepartment of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Junji UmenoDepartment of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yuta FuyunoDepartment of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Zhenqiu LiuF. Widjaja Family Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Centre, Los Angeles, CA, USA.
Dalin LiF. Widjaja Family Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Centre, Los Angeles, CA, USA.
Takeru NakanoDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yasuhiro IzumiyamaDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Ryo IchikawaDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Daisuke OkamotoDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Hiroshi NagaiDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Shin MatsumotoDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Katsutoshi YamamotoDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Naonobu YokoyamaDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Hirofumi ChibaDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yusuke ShimoyamaDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Motoyuki OnoderaDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Rintaro MoroiDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Masatake KurohaDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yoshitake KanazawaDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Tomoya KimuraDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Hisashi ShigaDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Katsuya EndoDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Kenichi NegoroDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Jun YasudaTohoku Medical Megabank Organisation, Tohoku University, Sendai, Japan.
Motohiro EsakiDepartment of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Katsushi TokunagaDepartment of Human Genetics, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Minoru NakamuraClinical Research Centre, National Hospital Organisation [NHO] Nagasaki Medical Centre, Omura, Japan.
Takayuki MatsumotoDepartment of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Dermot P B McGovernF. Widjaja Family Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Centre, Los Angeles, CA, USA.
Masao NagasakiTohoku Medical Megabank Organisation, Tohoku University, Sendai, Japan.
Yoshitaka KinouchiHealth Administration Centre, Centre for the Advancement of Higher Education, Tohoku University, Sendai, Japan.
Tooru ShimosegawaDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Atsushi MasamuneDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Tohoku University · JPKyushu University · JPIwate Medical University · JPNagasaki Medical Center · JPThe University of Tokyo · JPTohoku Medical Megabank Organization · JP

Funding

Identify Serological Markers defined subgroups in CD patients using Bigdata toolsR21DK108140 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI LI, DALIN · 2016 to 2017
$481k
NIDDK NIH HHS R21 DK108140
6 · The paper itself

Abstract

BACKGROUND AND

aimsGenome-wide association studies [GWASs] of European populations have identified numerous susceptibility loci for Crohn's disease [CD]. Susceptibility genes differ by ethnicity, however, so GWASs specific for Asian populations are required. This study aimed to clarify the Japanese-specific genetic background for CD by a GWAS using the Japonica array [JPA] and subsequent imputation with the 1KJPN reference panel.

methodsTwo independent Japanese case/control sets (Tohoku region [379 CD patients, 1621 controls] and Kyushu region [334 CD patients, 462 controls]) were included. GWASs were performed separately for each population, followed by a meta-analysis. Two additional replication sets [254 + 516 CD patients and 287 + 565 controls] were analysed for top hit single nucleotide polymorphisms [SNPs] from novel genomic regions.

resultsGenotype data of 4 335 144 SNPs from 713 Japanese CD patients and 2083 controls were analysed. SNPs located in TNFSF15 (rs78898421, Pmeta = 2.59 × 10-26, odds ratio [OR] = 2.10), HLA-DQB1 [rs184950714, pmeta = 3.56 × 10-19, OR = 2.05], ZNF365, and 4p14 loci were significantly associated with CD in Japanese individuals. Replication analyses were performed for four novel candidate loci [p <1 × 10-6], and rs488200 located upstream of RAP1A was significantly associated with CD [pcombined = 4.36 × 10-8, OR = 1.31]. Transcriptome analysis of CD4+ effector memory T cells from lamina propria mononuclear cells of CD patients revealed a significant association of rs488200 with RAP1A expression.

conclusionsRAP1A is a novel susceptibility locus for CD in the Japanese population.

Indexed as

AdultCase-Control StudiesCrohn DiseaseFemaleGene Expression ProfilingGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansJapanMalePolymorphism, Single Nucleotiderap1 GTP-Binding ProteinsYoung AdultRAP1A protein, humanrap1 GTP-Binding ProteinsCrohn’s diseaseRAP1Asusceptibility gene

Identifiers

PMID30500874
PMCPMC7458277
OpenAlexW2903468583

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.